| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693782 | European Urology | 2017 | 10 Pages |
Abstract
A constellation of unfavorable molecular characteristics co-occur with intraductal and cribriform subpathologies in prostate cancer. Modern imaging for surveillance and treatment intensification trials should be considered in this adverse subgroup.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Melvin L.K. Chua, Winnie Lo, Melania Pintilie, Jure Murgic, Emilie Lalonde, Vinayak Bhandari, Osman Mahamud, Anuradha Gopalan, Charlotte F. Kweldam, Geert J.L.H. van Leenders, Esther I. Verhoef, Agnes Marije Hoogland, Julie Livingstone, Alejandro Berlin,